Fapon’s ADLM 2026 showcase looks bigger than a product launch. Here is the real diagnostics strategy
Fapon unveils AI-engineered PCR enzymes and Alzheimer’s biomarker reagents at ADLM 2026, targeting faster North American IVD development.
Medical Devices & Diagnostics